ORGANIGRAM GLOBAL INC (OGI.CA) Stock Fundamental Analysis
Canada - TSX:OGI - CA68617J1003 - Common Stock
2.11 CAD
-0.05 (-2.31%)
Overall OGI gets a fundamental rating of 3 out of 10. We evaluated OGI against 32 industry peers in the Pharmaceuticals industry. OGI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OGI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year OGI has reported negative net income.
In the past year OGI had a positive cash flow from operations.
In the past 5 years OGI always reported negative net income.
OGI had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.38%, OGI belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
OGI has a better Return On Equity (2.02%) than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.38% | ||
| ROE | 2.02% | ||
| ROIC | N/A |
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of OGI (3.47%) is better than 77.42% of its industry peers.
OGI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.47% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OGI has been increased compared to 1 year ago.
Compared to 5 years ago, OGI has more shares outstanding
OGI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.45, we must say that OGI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.45, OGI perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
OGI has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
OGI has a better Debt to Equity ratio (0.14) than 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.45 |
ROIC/WACCN/A
WACC7.91%
2.3 Liquidity
A Current Ratio of 2.59 indicates that OGI has no problem at all paying its short term obligations.
OGI's Current ratio of 2.59 is fine compared to the rest of the industry. OGI outperforms 64.52% of its industry peers.
A Quick Ratio of 1.42 indicates that OGI should not have too much problems paying its short term obligations.
OGI's Quick ratio of 1.42 is in line compared to the rest of the industry. OGI outperforms 58.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.88% over the past year.
Looking at the last year, OGI shows a very strong growth in Revenue. The Revenue has grown by 38.86%.
Measured over the past years, OGI shows a quite strong growth in Revenue. The Revenue has been growing by 14.73% on average per year.
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
3.2 Future
The Earnings Per Share is expected to grow by 19.96% on average over the next years. This is quite good.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 18.32% on average per year.
EPS Next Y119.5%
EPS Next 2Y41.55%
EPS Next 3Y28.91%
EPS Next 5Y19.96%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.32%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Forward Earnings ratio of 1392.74, OGI can be considered very expensive at the moment.
OGI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OGI is cheaper than 64.52% of the companies in the same industry.
OGI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1392.74 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OGI does not grow enough to justify the current Price/Earnings ratio.
OGI's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.55%
EPS Next 3Y28.91%
5. Dividend
5.1 Amount
No dividends for OGI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:OGI (11/14/2025, 7:00:00 PM)
2.11
-0.05 (-2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.05%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap283.44M
Revenue(TTM)223.82M
Net Income(TTM)7.77M
Analysts77.5
Price Target3.06 (45.02%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)376.4%
Min EPS beat(2)-164.03%
Max EPS beat(2)916.83%
EPS beat(4)1
Avg EPS beat(4)56.27%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)3.01%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)6
Avg Revenue beat(12)-1.43%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)0%
PT rev (3m)11.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)138.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1392.74 | ||
| P/S | 1.27 | ||
| P/FCF | N/A | ||
| P/OCF | 102.92 | ||
| P/B | 0.74 | ||
| P/tB | 1 | ||
| EV/EBITDA | N/A |
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EY0.07%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.02
OCFY0.97%
SpS1.67
BVpS2.87
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.38% | ||
| ROE | 2.02% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.47% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 122.48% | ||
| Cap/Sales | 8.8% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.59 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | -0.45 |
F-Score3
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y119.5%
EPS Next 2Y41.55%
EPS Next 3Y28.91%
EPS Next 5Y19.96%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y18.32%
EBIT growth 1Y-79.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.17%
EBIT Next 3Y46.25%
EBIT Next 5Y30.71%
FCF growth 1Y78.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.64%
OCF growth 3YN/A
OCF growth 5YN/A
ORGANIGRAM GLOBAL INC / OGI.CA FAQ
Can you provide the ChartMill fundamental rating for ORGANIGRAM GLOBAL INC?
ChartMill assigns a fundamental rating of 3 / 10 to OGI.CA.
What is the valuation status of ORGANIGRAM GLOBAL INC (OGI.CA) stock?
ChartMill assigns a valuation rating of 1 / 10 to ORGANIGRAM GLOBAL INC (OGI.CA). This can be considered as Overvalued.
What is the profitability of OGI stock?
ORGANIGRAM GLOBAL INC (OGI.CA) has a profitability rating of 2 / 10.
What is the earnings growth outlook for ORGANIGRAM GLOBAL INC?
The Earnings per Share (EPS) of ORGANIGRAM GLOBAL INC (OGI.CA) is expected to grow by 119.5% in the next year.